free express shipping on orders over AUD$150
Checkout: 0

Your Cart is Empty

USD
AUD
NZD
GBP
EUR
CAD
HKD
SGD
JPY

Do you suffer from plaque psoriasis? Have you considered participating in a research trial?

Do you suffer from plaque psoriasis? Have you considered participating in a research trial?

At Solbari we believe in raising awareness and giving back. We proudly support the Skin & Cancer Foundation Inc., and have an opportunity for people affected by psoriasis.

Psoriasis is a chronic skin condition which is represented by patches of abnormal skin. The affected areas of skin are typically reddish in colour, itchy, scaly and dry. Psoriasis can be localised or cover many skin areas in extreme cases.

There are five different types of psoriasis but the most common type is called plaque psoriasis which accounts for 90 percent of cases. The areas of the body most commonly impacted by psoriasis include the back, scalp forearms and shins.

You can make a difference by participating in a clinical trial and work collectively with the Skin & Cancer Foundation Inc. team to find better solutions for complex skin issues.

Do you or someone you know suffer from plaque psoriasis?

The Skin & Cancer Foundation is seeking adults 18+ with a diagnosis of moderate to severe plaque psoriasis to participate in a 52 week research study.

To be eligible, participants must have psoriasis that covers 10% or more of their body surface area.

Participants will receive investigational study medication (active drug) or placebo (inactive drug).

Reimbursement for study-related expenses will be provided.

For more information visit:
https://www.skincancer.asn.au/page/103/current-clinical-trials

Facts:

  • Clinical Trials Manager Sarah Chivers is on hand to answer any questions you might have. Please call (03) 9623 9465.
  • The team consists of Sarah, Irena, Tracy, Dr. Natalie Wong and is led by A/Professor Peter Foley – expert in psoriasis treatment.
  • The trial runs for 52 weeks: you will be required to visit the S&CF on 5 occasions in the first 6-7 weeks and then every month until the conclusion of the trial.

For further information, please visit:
https://www.skincancer.asn.au/page/103/current-clinical-trials or contact the clinical trials team:

Dr Natalie Wong - telephone: (03) 9623 9400, email: nwong@skincancer.asn.au

Sarah Chivers - telephone: (03) 9623 9465, email: schivers@skincancer.asn.au

Solbari Sensitive Range

Solbari has developed a sensitive fabric range that caters to those with sensitive skin. Our Sensitive fabric is made from a blend of organic cotton & bamboo fibres that are super soft in texture, help regulate body temperature in warm conditions.

Solbari is the leading Australian sun protective clothing brand with customers in over 70 countries.

You can find out more about Solbari's certified UPF50+ sensitive range by clicking the blue links below:  
Women UPF50+ Sensitive Range
Men UPF50+ Sensitive Range



Also in Solbari Skin Health Blog

5 common skin cancer myths busted
5 common skin cancer myths busted

When it comes to skin cancer, there are a few misconceptions which can potentially put your skin at risk. We've debunked 5 common skin cancer myths that you may not know.
Read More
Can skin damage caused by the sun be repaired or even reversed?
Can skin damage caused by the sun be repaired or even reversed?

Your skin is your largest organ and has a long memory. Sun exposure and ultraviolet (UV) damage is cumulative throughout your life. Research shows that sun damage contributes to more than 90% of wrinkles, brown spots, premature skin ageing as well as precancerous and cancerous skin lesions.

 

 

Read More
The A B C D E of skin checking
The A B C D E of skin checking

It is very difficult to the untrained eye to identify melanomas and skin cancers because they can come in many different shapes and sizes.  

As Associate Professor Rosemary Nixon from the Skin & Cancer Foundation Inc. says, "the earlier a skin cancer is identified and treated, the better the chance of avoiding surgery, or in the case of a serious melanoma or skin cancer, potential disfigurement or even death."

Read More